According to LabCorp's latest financial reports the company has $0.39 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.43 B | -70.8% |
2021-12-31 | $1.47 B | 11.5% |
2020-12-31 | $1.32 B | 291.35% |
2019-12-31 | $0.33 B | -20.92% |
2018-12-31 | $0.42 B | 34.76% |
2017-12-31 | $0.31 B | -26.96% |
2016-12-31 | $0.43 B | -39.48% |
2015-12-31 | $0.71 B | 23.52% |
2014-12-31 | $0.58 B | 43.56% |
2013-12-31 | $0.40 B | -13.45% |
2012-12-31 | $0.46 B | 193.03% |
2011-12-31 | $0.15 B | -30.95% |
2010-12-31 | $0.23 B | 55.35% |
2009-12-31 | $0.14 B | -32.41% |
2008-12-31 | $0.21 B | 32.11% |
2007-12-31 | $0.16 B | -11.02% |
2006-12-31 | $0.18 B | 196.2% |
2005-12-31 | $63.1 M | -69.49% |
2004-12-31 | $0.20 B | 68.13% |
2003-12-31 | $0.12 B | 118.09% |
2002-12-31 | $56.4 M | -62.2% |
2001-12-31 | $0.14 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | $0.11 B | -71.73% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $0.17 B | -55.57% | ๐บ๐ธ USA |
![]() Translate Bio
TBIO.defunct | N/A | N/A | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | $0.43 B | 11.19% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $1.41 B | 260.06% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | $5.05 M | -98.72% | ๐บ๐ธ USA |